Search results for "nap"

showing 10 items of 2226 documents

Nrg1 haploinsufficiency alters inhibitory cortical circuits

2021

Neuregulin 1 (NRG1) and its receptor ERBB4 are schizophrenia (SZ) risk genes that control the development of both excitatory and inhibitory cortical circuits. Most studies focused on the characterization ErbB4 deficient mice. However, ErbB4 deletion concurrently perturbs the signaling of Nrg1 and Neuregulin 3 (Nrg3), another ligand expressed in the cortex. In addition, NRG1 polymorphisms linked to SZ locate mainly in non-coding regions and they may partially reduce Nrg1 expression. Here, to study the relevance of Nrg1 partial loss-of-function in cortical circuits we characterized a recently developed haploinsufficient mouse model of Nrg1 (Nrg1tm1Lex). These mice display SZ-like behavioral d…

Cortical neuronsReceptor ErbB-4Neuregulin-1Gene ExpressionneuronsNeurosciences. Biological psychiatry. NeuropsychiatryHaploinsufficiencyBiologyInhibitory postsynaptic potentialHippocampusMagnetic&nbspMiceInterneuronsNeuregulin 3mental disordersMagnetic resonance spectroscopyAnimalsRNA MessengerneurotransmissionNeuregulin 1GABAergic Neuronsgamma-Aminobutyric AcidInhibitory&nbspCerebral CortexNrg1resonance spectroscopyNeural InhibitionMagnetic Resonance ImagingCortex (botany)Inhibitory neurotransmissionParvalbuminsNeurologyInhibitory Postsynaptic PotentialsCalbindin 2Vesicular Glutamate Transport Protein 1biology.proteinExcitatory postsynaptic potentialSchizophreniaCalretininHaploinsufficiencyCortical&nbspNeuroscienceParvalbuminRC321-571Neurobiology of Disease
researchProduct

Quantification of cranial convergences in arvicolids (Rodentia)

1997

Cranial convergence in nine species of arvicolids is quantified phenetically using geometric morphometry. In a preliminary step, a hypothesis about phyletic relationships is proposed as a framework against which to examine morphological comparisons. The cranial morphology is then depicted in three series of 37, 20 and 13 landmarks characterizing the lower, upper and lateral sides of the skull respectively. Superimposition (Procrustes) methods are used to quantify shape differences and establish phenograms for the three sides of the skull. The phenogram obtained for lateral sides reveals a strong connection between skull profile and mode of life: surface dwelling forms have elongated skulls …

Cranial morphologybiologymedia_common.quotation_subjectEcological dataAnatomybiology.organism_classificationSkullmedicine.anatomical_structureMyopus schisticolorLagurusmedicineSynaptomys cooperiProcrustes analysisPhyletic gradualismEcology Evolution Behavior and Systematicsmedia_commonBiological Journal of the Linnean Society
researchProduct

Creative Tourism. Connecting Fontanelle Cemetery to a Larger Touristic Route

2021

The case study of this paper concerned the Fontanelle cemetery, an underground site with a long and peculiar history shaped by its origin, use and function as well as from its location, Rione Sanità. This area is a popular neighbourhood of Naples with original characteristics and challenges that we tried to learn, understand, and approach. The task of this work was to develop a strategy to connect the site to a larger touristic route through the implementation of Creative Tourism approaches.

Creative TourismValorizationSettore ICAR/17 - DisegnoNaplesUnderground HeritageHeritage Enhancement
researchProduct

(Z)-4-(2-Naphthylamino)pent-3-en-2-one

2011

The title compound, C15H15NO, which was synthesized under solvent-free conditions by the reaction of acetoacetone and 2-naphthylamine, adopts a Z conformation about the C=C bond. The enamine–ketone fragment is approximately planar [maximum deviation = 0.026 (3) Å] and forms a dihedral angle of 39.78 (3)° with the naphthalene ring system. An intramolecular N—H...O hydrogen bond is observed.

CrystallographyHydrogen bondMaximum deviationGeneral ChemistryDihedral angleCondensed Matter PhysicsRing (chemistry)BioinformaticsOrganic Paperschemistry.chemical_compoundCrystallographychemistryQD901-999General Materials ScienceNaphthaleneActa Crystallographica Section E
researchProduct

Noisot, Rude et Napoléon : le pouvoir de résurrection de la sculpture

2011

International audience

Cultural StudiesHistorySculpture[SHS.DROIT] Humanities and Social Sciences/Lawmedia_common.quotation_subjectNoisotArt[ SHS.DROIT ] Humanities and Social Sciences/LawNapoléon[SHS.DROIT]Humanities and Social Sciences/LawRudeHumanitiesSocial Sciences (miscellaneous)ComputingMilieux_MISCELLANEOUSsculpturemedia_common
researchProduct

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with…

2017

Summary Background We ran a compassionate use nationwide programme (ABACUS) to provide access to ombitasvir, paritaprevir, and ritonavir, with dasabuvir, plus ribavirin for hepatitis C virus (HCV) genotype 1 infection and ombitasvir, paritaprevir, and ritonavir, plus ribavirin for HCV genotype 4 infection in patients with cirrhosis at high risk of decompensation while approval of these regimens was pending in Italy. Methods In this prospective observational study, we collected data from a compassionate use nationwide programme from March 17, 2014, to May 28, 2015. Patients with HCV genotype 1 infection and cirrhosis at high risk of decompensation were given coformulated ombitasvir (25 mg), …

CyclopropanesCompassionate Use TrialsLiver CirrhosisMalechemistry.chemical_compound0302 clinical medicine2-NaphthylamineHCV direct-acting antiviral mixed cryoglobulinemia RBVAnilides030212 general & internal medicineLongitudinal StudiesProspective StudiesChronicAdult; Aged; Anilides; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy Combination; Female; Genotype; Hepatitis C Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Macrocyclic Compounds; Male; Middle Aged; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; UracilSettore MED/12 - GastroenterologiaSulfonamidesDasabuvirHCV DAAGastroenterologyvirus diseasesValineMiddle AgedSettore MED/07 - Microbiologia e Microbiologia ClinicaHepatitis CTreatment OutcomeGastroenterology; HepatologyCombinationDrug Therapy Combination030211 gastroenterology & hepatologyFemalemedicine.drugAdultmedicine.medical_specialtyMacrocyclic CompoundsProlineGenotypeLactams MacrocyclicAdult; Aged; Anilides; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy Combination; Female; Genotype; Hepatitis C Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Macrocyclic Compounds; Male; Middle Aged; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Hepatology; GastroenterologyHepatitis C virus genotype 1 Hepatitis C virus genotype 4 decompensated liver cirrhosis antiviral therapy dasabuvir ombitasvir paritaprevirHepatology; GastroenterologyAntiviral Agents03 medical and health sciencesDrug TherapyInternal medicineRibavirinmedicineHumansDecompensationAdverse effectUracilAgedRitonavirHepatologybusiness.industryRibavirinHepatitis C ChronicVirologyOmbitasvirClinical trialchemistryParitaprevirRitonavirCarbamatesbusiness
researchProduct

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

2018

Purpose: To analyse safety and efficacy of treatment based on ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in the sub-group of GT1 patients older than 65 years. Methods: We collected data extracted from the ABACUS compassionate-use nationwide Italian programme, in patients with cirrhosis due to hepatitis C virus (HCV) Genotype-1 (GT1) or 4 and at high risk of decompensation. GT1-HCV-infected patients received once-daily ombitasvir/paritaprevir, with the pharmacokinetic enhancer ritonavir (25/150/100 mg) and twice-daily dasabuvir (250 mg) plus Ribavirin (RBV) (OBV/PTV/r + DSV + RBV) for 12 (GT1b) or 24 (GT1a) weeks. Endpoints were to evaluate safety and efficacy, the latter def…

CyclopropanesLiver CirrhosisMaleCirrhosis;Dasabuvir;Elderly;Ombitasvir;ParitaprevirCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged; 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C; Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy; Combination; GenotypeParitaprevirCirrhosis Dasabuvir Elderly Ombitasvir Paritaprevir Microbiology (medical) Infectious DiseasesCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy Combination; Genotype; Microbiology (medical); Infectious DiseasesHepacivirusGastroenterologychemistry.chemical_compound0302 clinical medicineElderly2-Naphthylamine80 and overMedicineAnilides030212 general & internal medicineChronicAged 80 and overSulfonamidesDasabuvirValineGeneral MedicineHepatitis CHepatitis CTreatment OutcomeInfectious DiseasesCirrhosisCombination030211 gastroenterology & hepatologyDrug Therapy CombinationFemaleDasabuvirMacrocyclic CompoundCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Microbiology (medical); Infectious Diseasesmedicine.drugHumanMicrobiology (medical)medicine.medical_specialtyMacrocyclic CompoundsProlineGenotypeLactams MacrocyclicSettore MED/12 - GASTROENTEROLOGIALiver CirrhosiSulfonamideAntiviral Agents03 medical and health sciencesDrug TherapyInternal medicineRibavirinHumansDecompensationUracilAgedHepatitisAntiviral AgentCirrhosiHepaciviruRitonavirbusiness.industryRibavirinSettore MED/09 - MEDICINA INTERNAAnilideBiomarkerHepatitis C Chronicmedicine.diseaseCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy Combination; GenotypeOmbitasvirOmbitasvirchemistryParitaprevirCarbamateRitonavirCarbamatesbusinessBiomarkers
researchProduct

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepa…

2017

Summary Real-world studies are relevant to complement clinical trials on novel antiviral therapies against chronic hepatitis C; however, clinical practice data are currently limited. This study investigated effectiveness and safety of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r)±dasabuvir (DSV)±ribavirin (RBV) for treatment of HCV genotype (GT) 1 and GT4 infection in a large real-world cohort. The German Hepatitis C Registry is an observational cohort study prospectively collecting clinical practice data on direct-acting antiviral therapies. Patients with GT1/4 infection treated with OBV/PTV/r±DSV±RBV were analysed. Effectiveness was assessed by sustained virologic response in 558 patients…

CyclopropanesLiver CirrhosisMaleHepacivirusSeverity of Illness IndexCohort Studieschemistry.chemical_compound0302 clinical medicine2-NaphthylamineGermanyMedicineAnilides030212 general & internal medicineSulfonamidesDasabuvirValineHepatitis CMiddle AgedViral LoadInfectious DiseasesTreatment Outcome030211 gastroenterology & hepatologyDrug Therapy CombinationFemalemedicine.drugAdultmedicine.medical_specialtyMacrocyclic CompoundsGenotypeProlineLactams Macrocyclic03 medical and health sciencesVirologyOmbitasvir/paritaprevir/ritonavirInternal medicineHumansUracilAgedRitonavirHepatologybusiness.industryHepatitis C Chronicmedicine.diseaseVirologyOmbitasvirDiscontinuationRegimenchemistryParitaprevirRitonavirCarbamatesbusinessJournal of viral hepatitis
researchProduct

The effect of kinetin on the photosynthetic apparatus of Sinapis alba

1980

The influence of kinetin during the development of primary leaves of Sinapis alba was investigated. Kinetin treatment (6 ppm) induced an increase of dry weight, of soluble reducing sugars, soluble protein, chlorophylls, carotenoids and cytochrome f; a higher ratio of chlorophyll a to chlorophyll b, higher rates of CO2 fixation per fresh weight and higher activity of nitrite reductase, were also found. These effects are comparable with strong and blue light adaptations. On the other hand, the Hill activity with ferricyanide as the electron acceptor, the rates of CO2 fixation per chlorophyll, the ratios of chlorophyll to cytochrome f and of protein to chlorophyll did not change. Therefore we …

Cytochrome fChlorophyll bChlorophyll aSinapisPlant physiologyCell BiologyPlant ScienceGeneral MedicineBiologyPhotosynthesisbiology.organism_classificationBiochemistrychemistry.chemical_compoundchemistryChlorophyllBotanyKinetinPhotosynthesis Research
researchProduct

The effect of indole-3-acetic-acid on the photosynthetic apparatus of Sinapis alba

1980

The influence of indole-3-acetic-acid (IAA) during the development of primary leaves of Sinapis alba was studied. IAA treatment (4 ppm ≈ 22.8 μM) caused a decrease of dry weight, soluble reducing sugars, soluble protein, chlorophylls, carotenoids and cytochrome f; it also caused a lower ratio of protein to chlorophyll, a lower ratio of chlorophyll a to chlorophyll b and a higher ratio of chlorophyll per cytochrome f. Furthermore, IAA treatment induced a significantly lower rate of CO2 fixation and a depressed nitrite reductase activity. Similar effects could also be observed in adaptation reactions brought about by red light and low-light (or shade) conditions.

Cytochrome fChlorophyll bChlorophyll abiologySinapisfood and beveragesPlant physiologyCell BiologyPlant ScienceGeneral MedicinePhotosynthesisbiology.organism_classificationBiochemistrychemistry.chemical_compoundchemistryChlorophyllBotanyFood scienceIndole-3-acetic acidPhotosynthesis Research
researchProduct